CVS Group (LON:CVSG) Insider Robin Alfonso Purchases 768 Shares of Stock

CVS Group plc (LON:CVSG) insider Robin Alfonso purchased 768 shares of the firm’s stock in a transaction on Thursday, August 6th. The stock was bought at an average cost of GBX 1,294 per share, with a total value of £9,937.92.

CVS Group Stock Performance

Shares of LON CVSG traded up GBX 6 during midday trading on Thursday, reaching GBX 1,295. 81,360 shares of the stock were exchanged, compared to its average volume of 965,233. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 92.34. The firm has a market cap of £896.14 million, a price-to-earnings ratio of 18.80, a PEG ratio of 1.77 and a beta of 1.06. The firm has a 50-day simple moving average of GBX 1,231.89 and a two-hundred day simple moving average of GBX 1,242.49. CVS Group plc has a twelve month low of GBX 1,062 and a twelve month high of GBX 1,648.

CVS Group announced that its Board of Directors has initiated a share buyback program on Tuesday, May 26th that permits the company to buyback 0 outstanding shares. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

A number of brokerages have weighed in on CVSG. Berenberg Bank reiterated a “buy” rating and issued a GBX 2,000 price objective on shares of CVS Group in a research report on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 1,700 target price on shares of CVS Group in a research report on Monday, July 27th. Finally, Jefferies Financial Group lifted their price target on CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a research note on Friday, July 31st. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of GBX 1,720.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.